DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium

... initiatives in the areas of CKD, new incident dialysis patients, and integrated pharmacy management. ... presentation: -- Title: First Year dialysis Mortality in Patients Previously Enrolled ... and Clinical Outcomes of US Pediatric dialysis Patients at A ...

DaVita Abstracts Highlight Latest Research Developments at Annual Dialysis Conference

... in five abstracts at the Twenty-ninth Annual dialysis Conference (ADC) in Houston, TX. The spectrum of ... and a provider who serves more than 1-in-4 dialysis patients in the nation, we will continue our ... indicate educating patients before they begin dialysis will have an impact on their health and quality ...

For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold

... (AV) fistulas -- vascular accesses needed for dialysis treatment -- responded just as well as those in ... renal disease -- treatment in the form of regular dialysis (or hemodialysis) is needed to replace the ... fluids. The clean blood is then returned to a dialysis patient's ....

Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients

... hyperphosphatemia patients. - Qualified dialysis patients can receive grants to help with ... the blood phosphorus levels of many patients on dialysis often exceed 6.5 mg/dL. Such levels have been ... and phosphorus-binding agents, because diet and dialysis alone generally cannot adequately control ...

NxStage(R) to Recognize Several Key Milestones at American Society of Nephrology's Renal Week 2007

... NxStage, the leading manufacturer of dialysis machines indicated for home use and the first ... The System One is now available at over 300 dialysis centers in markets throughout the United States. ... for home use by the FDA. Unlike traditional dialysis equipment, the System One plugs into a standard ...

Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks

... published today in The Lancet has shown that dialysis patients were effectively switched from ... study to investigate the direct conversion of dialysis patients with chronic kidney disease from ... patients with stable chronic renal anemia on dialysis therapy and IV maintenance epoetin at 91 ...

New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting

... C.E.R.A. maintains stable hemoglobin (Hb) in dialysis patients (pts), irrespective of age or gender. S. ... are maintained with once-monthly C.E.R.A. in dialysis patients (pts), irrespective of mode of vascular ... disease (CKD), regardless of albumin or dialysis adequacy (Kt/V). W. Sulowicz et al. ...

Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study

... consisting of up to 130 patients at multiple dialysis centers in the United States. The primary ... stated, "Beginning the successful dosing of dialysis patients is another significant milestone in our ... by delivering iron via dialysate during dialysis treatments. SFP is a highly stable and ...

Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study

... consisting of up to 130 patients at multiple dialysis centers in the United States. Patients will receive SFP during their normal three times/week dialysis regimen. The primary objectives of this study are ... the dialysate directly to the blood during the dialysis session. Results of this Phase IIb study ...

Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients

... with chronic kidney disease and those on dialysis depend on ESAs to stimulate red blood cell ... recommended that ESA therapy in dialysis and non- dialysis CKD patients should target hemoglobin levels ... and their advocates, nephrologists, nurses, dialysis care providers, and manufacturers who have joined ...

Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172

... quarter of 2009." Approximately 450,000 CABG procedures, 50 million dialysis procedures, and 1.2 million PCIs are performed annually in the U.S. During ... during procedures such as coronary artery bypass graft surgery, kidney dialysis and percutaneous coronary interventions. Data from the Phase 1 trial ...

Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)

... persons in hospitals and healthcare facilities, such as nursing homes and dialysis centers, who have weakened immune systems. MRSA infections that occur in ... recently hospitalized or who have undergone a medical procedure such as dialysis or surgery, are known as community-associated (CA-MRSA) infections. These ...

DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education

... those most at risk for kidney failure, learn how to adjust to life on dialysis by controlling their diet, taking the proper medications and choosing the ... is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end ...

Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program

... renal program which includes pharmacy delivery of required medications to dialysis patients and CKD disease management. "Genzyme Corporation selected ... help support Genzyme's premier national renal program that will assist dialysis patients to gain access to required medications and achieve optimal ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

... or TEKTURNA HCT and contact your doctor immediately), and low blood pressure, especially if you take water pills, are on a low-salt diet, get dialysis treatments, have heart problems, or get sick with vomiting or diarrhea. Lie down if you feel faint or dizzy. Call your doctor right away. In ...

WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center

... home and found her passed out close to death on the floor. Soon after, doctors told her that her kidneys had failed and that she would need to have dialysis until a kidney donor was found. They were referred to The Renal and Pancreas Transplant Division at Saint Barnabas Medical Center. Once at the ...

Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy

... Over time kidney function becomes compromised and over the course of 10-20 years the inflammation can lead to end-stage renal disease requiring dialysis or kidney transplant. Current treatments for IgA nephropathy include blood pressure control, diet and immunosuppressant drugs. Approximately 30 ...

Schering-Plough Announces Results of the Early ACS Trial

... dose of INTEGRILIN needs to be reduced to 1mcg/kg/min in these patients; INTEGRILIN is contraindicated in patients who are dependent upon renal dialysis (please see dosing guidelines); caution should be exercised when administering INTEGRILIN to patients with a platelet count <100,000/mm3. Bleeding ...

Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients

... Hospital in Jerusalem, Israel. The trial's sponsors and Principal Investigators are now seeking approval to broaden the study to include dialysis patients as well as pre-dialysis patients. More information on this will be announced as developments proceed. The Company's active discussions ...

Freezing Kidney Cancer: Hot Treatment Should Be New Gold Standard for Destroying Small Tumors

... kidney cancer are past the age of 40 and are twice as likely to be men. Other risk factors include smoking, obesity, high blood pressure, long-term dialysis and Von Hippel-Lindau syndrome. About the Society of Interventional Radiology Interventional radiologists are physicians who specialize in ...

Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function

... of the transplanted kidney (graft survival). Currently there is no marketed treatment for DGF; when DGF is diagnosed the patient is supported with dialysis and other supportive care. The investigational drug candidate QPI-1002 is a siRNA designed to temporarily inhibit the expression of the ...

First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting

... kidney injury and progressing to end-stage kidney disease. Those who survive aHUS often live with irreversible kidney disease and are dependent upon dialysis to stay alive. "Our first clinical experience with eculizumab in patients with aHUS is very promising, especially given the devastating ...

Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion

... is an ESA used for the treatment of anemia in patients with most types of cancer receiving chemotherapy, with chronic renal failure who are on dialysis and those who are not on dialysis, who are being treated with zidovudine for HIV infection, and to reduce the need for transfusion in anemic patients ...

PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.

... mortality rates, and increases in long-term mortality rates, major in-hospital adverse cardiac events, and the risk of having to undergo renal dialysis therapy. Any of these can result in prolonged hospital stays and increased medical costs. Studies indicate that approximately 15-20% of all ...

Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques

... United States to evaluate the long-term benefit of the ResQPOD for indications related to patients suffering from cardiac arrest, hypotension during dialysis and severe blood loss. The references in this communication are not intended to imply specific outcome-based claims not yet cleared by the US Food ...

Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success

... said Sudarshan Hebbar, M.D., senior medical director, Abbott Diagnostics. "Unfortunately, most kidney transplant patients will go back on dialysis in eight to ten years, in part because the anti-rejection drugs can be toxic to the kidneys." Dr. Hebbar added that kidney-transplant patients have ...

PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S.

... mortality rates, and increases in long-term mortality rates, major in-hospital adverse cardiac events, and the risk of having to undergo renal dialysis therapy. Any of these can result in prolonged hospital stays and increased medical costs. Studies indicate that approximately 15-20% of all patients ...

Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products

... and pleased to have reached this important milestone. There is a broad range of literature supporting the advantages of hemodiafiltration (HDF) over dialysis for the ESRD patient, including studies supporting a substantial reduction in the relative risk of mortality. While HDF is prevalent in Europe, no ...

PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)

... mortality rates, and increases in long-term mortality rates, major in-hospital adverse cardiac events, and the risk of having to undergo renal dialysis therapy. Any of these can result in prolonged hospital stays and increased medical costs. Studies indicate that approximately 15-20% of all patients ...

New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... alfa) is an ESA used for the treatment of anemia in patients with most types of cancer receiving chemotherapy, with chronic renal failure who are on dialysis and those who are not on dialysis, who are being treated with zidovudine for HIV infection, and to reduce the need for transfusion in anemic patients ...

Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients

... estimated 20-30 percent of diabetic patients will progress to diabetic kidney disease,(6) a devastating disease that may require patients to undergo dialysis or a kidney transplant.(7) Pharmacopeia recently initiated a 12-week, Phase 2b clinical trial with PS433540 to evaluate the compound's safety and ...

Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device

... including the brain and kidneys, and suppressing the function and regeneration of the liver. SEPET(TM) is designed for use with standard blood dialysis systems available in hospital intensive care units. According to the American Liver Foundation, liver disease is among the top seven causes of ...

DaVita Clinical Research Completes Record Number of Renal Trials in 2007

... respective owners. About DaVita Inc. DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,300 outpatient facilities and ...

St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable

... and the cancer recurs in the other kidney, the possibility of losing renal function is high. If both kidneys are removed, the child must endure dialysis and a possible kidney transplant. "In most cases, the surgeon will be able to save normal kidney on both sides," Davidoff said. "The study ...

PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.

... mortality rates, and increases in long-term mortality rates, major in-hospital adverse cardiac events, and the risk of having to undergo renal dialysis therapy. Any of these can result in prolonged hospital stays and increased medical costs. Studies indicate that approximately 15-20% of all patients ...

Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)

... including the brain and kidneys, and suppressing the function and regeneration of the liver. SEPET(TM) is designed for use with standard blood dialysis systems available in hospital intensive care units. According to the American Liver Foundation, liver disease is among the top seven causes of ...

PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)

... mortality rates, and increases in long-term mortality rates, major in-hospital adverse cardiac events, and the risk of having to undergo renal dialysis therapy. Any of these can result in prolonged hospital stays and increased medical costs. Studies indicate that approximately 15-20% of all patients ...

Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA

... that 85 percent of these infections are picked up by patients exposed to MRSA in hospitals and other healthcare settings, like nursing homes and dialysis centers. APIC's most recent survey found that 41 percent of infection control professionals said their healthcare facility had not taken any ...

Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH

... untreated population of PNH patients to a major clinical kidney event, including severe renal damage, renal insufficiency, renal impairment, dialysis and later-stage CKD, was approximately 87 percent. In an analysis of the overall PNH study population, long-term Soliris therapy of up to 18 months ...

Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis

... partnered with Toray Industries, Inc. of Japan on the development and commercialization of AC-820 (TRK-820) for the treatment of uremic pruritus in dialysis patients. Acologix is preparing for a Phase III study with this compound for uremic pruritus in the United States for 2008. AC-100 (Dentonin(R)), a ...